ArticleFrontiers in public health2025
Population-level barriers to home hemodialysis implementation: a public health systems analysis of adoption readiness, health equity, and policy implications in China.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Home hemodialysis (HHD) can improve clinical outcomes and reduce system costs, yet utilization remains negligible in mainland China. This study quantified population-level willingness to adopt HHD and identified multilevel determinants with direct relevance to service delivery, equity, and implementation. Methods: A cross-sectional survey was conducted at a tertiary dialysis center in Huzhou, China (February 2022-November 2025) among consecutive adults receiving thrice-weekly in-center hemodialysis for ≥3 months. The primary outcome was high HHD adoption intent (Likert 4-5). Multivariable logistic regression, with bootstrap validation, estimated independent associations across sociodemographic, clinical, psychosocial, infrastructural, economic, and health-system engagement domains. Results: Of 2,847 participants (72% response rate), 717 (25.2%) reported high adoption intent. High-intent patients were younger (54.8 ± 13.7 vs. 59.6 ± 14.3 years), more often male (61.6% vs. 54.3%), employed (58.7% vs. 44.4%), and university-educated (18.1% vs. 14.5%). Favorable clinical, psychosocial, and system-readiness profiles were observed, including arteriovenous fistula use (71.4% vs. 61.5%), higher Kt/V (1.35 ± 0.27 vs. 1.26 ± 0.28), greater knowledge (9.0 vs. 5.0), and prior HHD discussion. The model showed strong discrimination (optimism-corrected AUC = 0.82). Independent facilitators included prior HHD discussion (OR 2.18, 95% CI: 1.78-2.67), university education (2.12, 1.58-2.84), arteriovenous fistula (1.87, 1.41-2.48), and perceived effectiveness (1.52 per point, 1.32-1.75); age, comorbidity, and perceived risk were deterrents. High-intent patients had fewer emergency visits, better adherence, and lower total dialysis costs. Conclusion: A quarter of Chinese dialysis patients are interested in HHD, revealing significant latent demand. Adoption can be boosted by addressing key facilitators such as provider education, patient knowledge, vascular access, and cannulation anxiety. Since HHD-ready patients have better outcomes and lower healthcare costs, targeted expansion offers an evidence-based strategy to improve health equity, reduce the burden on the health system, and strengthen financial protection for vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.